Letter: Persisting clinical symptoms in microscopic colitis in remission--authors' reply (original) (raw)

2018

Ten Common Errors in the Management of Inflammatory Bowel Disease

Inflammatory Bowel Diseases, 2003

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

George Kolios

European Journal of Clinical Pharmacology, 2009

View PDFchevron_right

High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors

Ali Keshavarzian

Alimentary pharmacology & therapeutics, 2016

View PDFchevron_right

Phenotype of histologically suspected drug-induced colitis; results of a comparative, retrospective cohort study

Thorsten Brechmann

Scandinavian Journal of Gastroenterology, 2019

View PDFchevron_right

Is Microscopic Colitis a Drug-induced Disease?

Marieke Pierik

Journal of Clinical Gastroenterology, 2012

View PDFchevron_right

A review of the gastrointestinal safety data--a gastroenterologist's perspective

Angel Lanas

Rheumatology, 2010

View PDFchevron_right

GASTROINTESTINAL COMPLICATIONS DURING USE OF ANTI-INFLAMMATORY DRUGS FOR ORTHOPEDIC DISEASES

Giovanni Tomasello, GIOVANNI TOMASELLO

View PDFchevron_right

The GETECCU clinical guideline for the treatment of ulcerative colitis: A guideline created using GRADE methodology

Santiago García-lópez

2013

View PDFchevron_right

DISCUSSION ABOUT TREATMENT OF ULCERATIVE COLITIS.

IJAR Indexing

View PDFchevron_right

Update on the Management of Ulcerative Colitis

Frank Hoentjen

Current Gastroenterology Reports, 2011

View PDFchevron_right

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

Lee Hooper

BMJ, 2004

View PDFchevron_right

Ulcerative colitis: an update

Jonathan Segal

Clinical Medicine, 2021

View PDFchevron_right

Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development

Klaus Gottlieb

View PDFchevron_right

Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?

Neville Yeomans

BMC Medicine, 2015

View PDFchevron_right

Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis

Tomas Soukup

Rheumatology International, 2016

View PDFchevron_right

Therapeutic updates for moderate to severe ulcerative colitis

Dr. Sumona Bhattacharya

Digestive Medicine Research, 2020

View PDFchevron_right

ECCO-EFCCA Patient Guidelines on Ulcerative Colitis ( UC )

Gediminas Smailys

2016

View PDFchevron_right

Drug Exposure and Risk of Microscopic Colitis

Morten Fenger-Grøn

Inflammatory Bowel Diseases, 2014

View PDFchevron_right

W1927 Low Dose Aspirin Affects the Small Bowel Mucosa. Results of a Pilot Study Using a Multidimensional Assessment

Alejandro Suarez

Gastroenterology, 2008

View PDFchevron_right

Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment

Alejandro Suarez

Clinical Gastroenterology and Hepatology, 2009

View PDFchevron_right

A meta-analysis of antibiotic therapy for active ulcerative colitis

Shekoufeh Nikfar

Digestive diseases and …, 2007

View PDFchevron_right

A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract

Martin Stillman

The Journal of Rheumatology, 2010

View PDFchevron_right

Assessing disease activity in ulcerative colitis: Patients or their physicians?

David Mack

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)

Professor Laith Al-Rubaiy PhD, FRCP

BMJ Open, 2014

View PDFchevron_right

REVIEW ARTICLE Update on the Management of Ulcerative Colitis

Nasser Daryani

2012

View PDFchevron_right

Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: Defining the role of gastroprotective agents

D. Morgan, Ford Bursey

2000

View PDFchevron_right

Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs

Luis Uscanga

Revista de Gastroenterología de México (English Edition), 2016

View PDFchevron_right

European evidence-based Consensus on the management of ulcerative colitis: Special situations

Willem Bemelman

2008

View PDFchevron_right

Letter: Persisting clinical symptoms in microscopic colitis in remission--authors' reply (original) (raw)

Related papers